Faeth Therapeutics Stock Performance
as on September 16, 2026 at 2:15 pm IST
Day's Low
Day's High
$34.88$39.52
1.39%
Downside
11.73%
Upside
52 Week's Low
52 Week's High
100.00%
Downside
-100.00%
Upside
Faeth Therapeutics share price movements today
- Previous Close
- $39.09
- Open
- $38.75
- Volume
- 355.2K
- Market Cap
- $967.5M
- Day's Low - High
- $34.88 - $39.52
Faeth Therapeutics Historical Returns
- 1 Month Return
- + 20.87 %
- 3 Month Return
- 0 %
- 1 Year Return
- 0 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
Faeth Therapeutics Stock Fundamentals & Key Indicators
Check Faeth Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$967.5M
EPS (TTM)
-141.65
Dividend Yield
0.00%
PE Ratio (TTM)
-0.26
Industry PE ratio
-6.33
PEG Ratio
0.0002881608551472336
Return On Equity TTM
-192.76%
Faeth Therapeutics Stock Valuation
Track how Faeth Therapeutics P/E has moved over time to understand its valuation trends.
Faeth Therapeutics in the last 5 years
Lowest (-87.36x)
December 31, 2021
Industry (-6.33x)
December 31, 2025
Today (-0.64x)
December 31, 2025
Highest (-0.64x)
December 31, 2025
Today’s Price to Earnings Ratio: -0.64x
Faeth Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Faeth Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $967.5M | NA | -0.26 | 2740.82% | NA | |
| BUY | $44.6B | 614.61% | NA | 0.00% | NA | |
| BUY | $130.6B | 175.08% | 29.76 | 86.04% | NA | |
| BUY | $57.5B | -66.24% | -18.04 | -12.57% | NA | |
| BUY | $80.5B | 21.74% | 18.95 | 84.86% | 47.339999999999996% |
Analyst Recommendation on Faeth Therapeutics Stock
Based on 11 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 11 analysts, 100% of analysts recommend a 'BUY' rating for Faeth Therapeutics. Average target price of $56.4
Indian Investors' Interest in Faeth Therapeutics Stock
Search interest for Faeth Therapeutics Stock has decreased by -4% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Faeth Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Faeth Therapeutics Annual Profit & Loss
All numbers in Millions USD
Faeth Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Faeth Therapeutics Annual Cash Flow
All numbers in Millions USD
Faeth Therapeutics News & Key Events
Today's Timeline - 09 September
Wed, 03:40 PM
-TD Cowen initiates coverage of Faeth Therapeutics with a Buy rating, highlighting strong potential and upcoming Phase 2 data.
Insights on Faeth Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 3 Years
In the last 3 years, FTH has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Price Rise
In the last 3 months, FTH stock has moved up by 143.4%
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 478.8% return, outperforming this stock by 181.4%
About Faeth Therapeutics
| Organisation | Faeth Therapeutics |
| Headquarters | 1405 Research Boulevard, Rockville, MD, United States, 20850 |
| Industry | Biotechnology |
| CEO | Mr. Anand Parikh Esq., J.D. |
| E-voting on shares | Click here to vote |
Key Management of Faeth Therapeutics
Name | Title |
|---|---|
Mr. Christopher W. Gerry J.D. | General Counsel & Secretary |
Mr. Anand Parikh Esq., J.D. | CEO, President & Chair |
Dr. Siddhartha Mukherjee DPHIL, M.D., Ph.D. | Scientific Co-Founder |
Dr. Lewis clayton Cantley Ph.D. | Scientific Co-Founder |
Dr. Scott W. Lowe Ph.D. | Scientific Co-Founder |
Dr. Gregory J. Hannon Ph.D. | Scientific Co-Founder |
Dr. Karen H. Vousden Ph.D. | Scientific Co-Founder |
Dr. Benjamin Hopkins Ph.D. | Scientific Co-Founder |
Mr. Josiah Craver CPA | Senior VP of Finance, Principal Financial Officer & Principal Accounting Officer |
Mr. Oliver Maddocks Ph.D. | Co-Founder & Chief Scientific Officer |
FAQs
What is Faeth Therapeutics share price today?
Faeth Therapeutics share price today is $35.37 as on at the close of the market. Faeth Therapeutics share today touched a day high of $39.52 and a low of $34.88.
What is the 52 week high and 52 week low for Faeth Therapeutics share?
Faeth Therapeutics share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Faeth Therapeutics stock price today i.e. is closed at $35.37,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.
What is Faeth Therapeutics's market capitalisation today?
Faeth Therapeutics market capitalisation is $0.00T as on .
How to invest in Faeth Therapeutics Stock (FTH) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Faeth Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Faeth Therapeutics Shares that will get you 0.0424 shares as per Faeth Therapeutics share price of $35.37 per share as on September 16, 2026 at 8:45 am IST.
What is the minimum amount required to buy Faeth Therapeutics Stock (FTH) from India?
Indian investors can start investing in Faeth Therapeutics (FTH) shares with as little as ₹95.94 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.40 in Faeth Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Faeth Therapeutics share’s latest price of $35.37 as on September 16, 2026 at 8:45 am IST, you will get 0.2827 shares of Faeth Therapeutics. Learn more about
fractional shares .